Method for producing halogen oxyacid solution
US-12466732-B2 · Nov 11, 2025 · US
US9399576B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9399576-B2 |
| Application number | US-201414154810-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 14, 2014 |
| Priority date | Jan 14, 2014 |
| Publication date | Jul 26, 2016 |
| Grant date | Jul 26, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for degrading Rhodamine B including: mixing BiOBr and Rhodamine B; and irradiating the mixture with a radiation having a wavelength of from 440 nm to 554 nm. The Rhodamine B may be in an aqueous solution. The BiOBr may be added to the aqueous solution of Rhodamine B in an amount of from 0.2 to 0.5 mg/ml. The BiOBr may have a sheet-like structure with particles having a diameter of from 3 μm to 5 μm. The BiOBr may be in a pure crystal tetragonal phase.
Opening claim text (preview).
What is claimed is: 1. A method for degrading Rhodamine B comprising: mixing BiOBr and an aqueous solution of Rhodamine B; and irradiating the mixture with a radiation having a wavelength of from 440 nm to 554 nm, wherein the BiOBr is added to the aqueous solution of Rhodamine B in an amount of from 0.2 to 0.5 mg/ml, and wherein the BiOBr has a sheet-like structure with a diameter of from 3 μm to 5 μm. 2. The method of claim 1 , wherein the aqueous solution of the Rhodamine B is free of hydroxyl radical scavengers. 3. The method of claim 1 , wherein the mixture is irradiated with a radiation having a wavelength of 450 nm. 4. The method of claim 3 , wherein the radiation is monochromatic light. 5. The method of claim 1 , wherein the mixture is irradiated at a temperature of from 5° C. to 27° C. 6. The method of claim 1 , wherein the BiOBr is in a pure crystal tetragonal phase. 7. The method of claim 1 , wherein the BiOBr has a band gap of 2.8 eV. 8. The method of claim 1 , wherein the BiOBr is synthesized from sodium bismuth oxide dihydrate and hydrobromic acid. 9. The method of claim 1 , wherein at least 80% of the Rhodamine B is degraded after the irradiation for a period of 60 minutes. 10. The method of claim 1 , wherein the Rhodamine B is photosensitized by the irradiation. 11. The method of claim 1 , wherein BiOBr is the only catalyst present in the mixture during the mixing and the irradiating. 12. The method of claim 1 , wherein the BiOBr is added to the aqueous solution of Rhodamine B in an amount of from 0.3 to 0.5 mg/ml. 13. The method of claim 1 , wherein the BiOBr is added to the aqueous solution of Rhodamine B in an amount of from 0.4 to 0.5 mg/ml. 14. The method of claim 1 , wherein an initial concentration of RhB in the RhB aqueous solution is from 5 to 10 ppm. 15. The method of claim 1 , further comprising, after the irradiating, removing BiOBr from the mixture by centrifugation. 16. The method of claim 1 , wherein the BiOBr has a sheet-like structure with a diameter of about 4 μm. 17. The method of claim 8 , wherein the BiOBr is synthesized by fully dissolving sodium bismuth oxide dihydrate in an aqueous solution of hydrobromic acid, and adding water to precipitate the BiOBr.
Related publications grouped by family.
Answers are generated from the same data shown on this page.